EUVIMEDEUVIMED entdecken
Crossref

A new regulatory framework: impact of the SoHO Regulation for medically assisted reproduction

Fiorenza Bariani, Alessandra Alteri iD, Liliam Santilli, Maria Teresa Vicentini, Paola Di Ciaccio, Letizia Lombardini, Giuseppe Feltrin

Human Reproduction · 01.08.2026 · 41 (8) · 1237-1244

DOI: 10.1093/humrep/deag100 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 26.06.2026. Verfasst von Fiorenza Bariani und 6 weiteren Autor:innen. Beteiligte Einrichtung: Italian National Transplant Centre, National Institute of Health, Rome, Italy. Hauptthemen laut MEDLINE: Reproductive Techniques, Assisted. Die Arbeit nennt 7 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Regulation (EU) 2024/1938 on Substances of Human Origin (SoHO), adopted in June 2024 and entering into application from 7 August 2027, establishes a unified and legally binding framework for all human-derived materials used in clinical practice, explicitly encompassing gametes and embryos. By replacing the previous EU Tissues and Cells Directives, it introduces harmonized standards for authorization, vigilance, and traceability, while reinforcing donor, recipient, and offspring protection. This commentary examines the main regulatory innovations relevant to medically assisted reproduction (MAR) and critically assesses their expected impact through a SWOT (Strengths, Weaknesses, Opportunities, and Threats) analysis. The SoHO Regulation offers an unprecedented opportunity to strengthen safety, quality, and ethical governance in MAR through evidence-based oversight and harmonized technical standards. However, its implementation may also generate significant administrative burden, challenges in proportionality, and potential delays in innovation. Overall, the SoHO Regulation represents a milestone for reproductive medicine, offering the chance to elevate safety and equity across Europe, provided its implementation is proportionate and supported by adequate guidance and collaboration among competent authorities and MAR professionals.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Reproductive Techniques, AssistedHumansFemaleEuropean Union

Stichwörter der Autor:innen

Regulation (EU) 2024/1938SoHO RegulationSubstances of Human Origin (SoHO)assisted reproductive technologymedically assisted reproductionquality and safetyrisk-based regulationvigilance

Autor:innen und Institutionen

  • Italian National Transplant Centre, National Institute of Health, Rome, Italy.
  • Eye Bank, San Salvatore Hospital, L'Aquila, Italy.

ORCID-Profile: Alessandra Alteri

Zitieren

APA

Bariani, F., Alteri, A., Santilli, L., Vicentini, M. T., Di Ciaccio, P., Lombardini, L., & Feltrin, G. (2026). A new regulatory framework: impact of the SoHO Regulation for medically assisted reproduction. Human Reproduction, 41(8), 1237-1244. https://doi.org/10.1093/humrep/deag100

Vancouver

Bariani F, Alteri A, Santilli L, Vicentini MT, Di Ciaccio P, Lombardini L, et al. A new regulatory framework: impact of the SoHO Regulation for medically assisted reproduction. Human Reproduction. 2026;41(8):1237-1244. doi:10.1093/humrep/deag100

BibTeX
@article{Bariani2026,
  author = {Bariani, Fiorenza and Alteri, Alessandra and Santilli, Liliam and Vicentini, Maria Teresa and Di Ciaccio, Paola and Lombardini, Letizia and Feltrin, Giuseppe},
  title = {A new regulatory framework: impact of the SoHO Regulation for medically assisted reproduction},
  journal = {Human Reproduction},
  year = {2026},
  volume = {41},
  number = {8},
  pages = {1237--1244},
  doi = {10.1093/humrep/deag100}
}
Kostenlos starten →